JCRファーマの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2017/12/06 | 4,685 | 4,790 | 4,630 | 4,670 | -30 | -0.6% | 119,600 |
2017/12/05 | 4,640 | 4,715 | 4,585 | 4,700 | +60 | +1.3% | 93,500 |
2017/12/04 | 4,770 | 4,875 | 4,630 | 4,640 | -125 | -2.6% | 132,600 |
2017/12/01 | 4,650 | 4,770 | 4,625 | 4,765 | +105 | +2.3% | 109,200 |
2017/11/30 | 4,600 | 4,670 | 4,510 | 4,660 | +55 | +1.2% | 117,700 |
2017/11/29 | 4,710 | 4,725 | 4,585 | 4,605 | -105 | -2.2% | 116,400 |
2017/11/28 | 4,635 | 4,720 | 4,610 | 4,710 | +125 | +2.7% | 128,400 |
2017/11/27 | 4,620 | 4,630 | 4,535 | 4,585 | -30 | -0.7% | 70,500 |
2017/11/24 | 4,600 | 4,675 | 4,565 | 4,615 | +15 | +0.3% | 67,400 |
2017/11/22 | 4,730 | 4,800 | 4,595 | 4,600 | -75 | -1.6% | 155,800 |
2017/11/21 | 4,595 | 4,720 | 4,535 | 4,675 | +85 | +1.9% | 130,200 |
2017/11/20 | 4,600 | 4,740 | 4,535 | 4,590 | +35 | +0.8% | 217,300 |
2017/11/17 | 4,575 | 4,630 | 4,495 | 4,555 | +155 | +3.5% | 208,700 |
2017/11/16 | 4,290 | 4,420 | 4,265 | 4,400 | +90 | +2.1% | 104,300 |
2017/11/15 | 4,430 | 4,500 | 4,275 | 4,310 | -130 | -2.9% | 129,700 |
2017/11/14 | 4,365 | 4,465 | 4,355 | 4,440 | +85 | +2% | 73,600 |
2017/11/13 | 4,365 | 4,375 | 4,295 | 4,355 | -10 | -0.2% | 97,200 |
2017/11/10 | 4,350 | 4,440 | 4,295 | 4,365 | -60 | -1.4% | 137,300 |
2017/11/09 | 4,545 | 4,630 | 4,360 | 4,425 | -20 | -0.4% | 172,700 |
2017/11/08 | 4,400 | 4,525 | 4,380 | 4,445 | +30 | +0.7% | 107,900 |
2017/11/07 | 4,340 | 4,450 | 4,240 | 4,415 | +80 | +1.8% | 270,900 |
2017/11/06 | 4,700 | 4,725 | 4,295 | 4,335 | -300 | -6.5% | 247,200 |
2017/11/02 | 4,520 | 4,650 | 4,500 | 4,635 | +145 | +3.2% | 181,500 |
2017/11/01 | 4,530 | 4,620 | 4,485 | 4,490 | +20 | +0.4% | 212,300 |
2017/10/31 | 4,385 | 4,495 | 4,350 | 4,470 | -45 | -1% | 209,000 |
2017/10/30 | 4,320 | 4,595 | 4,265 | 4,515 | +220 | +5.1% | 590,800 |
2017/10/27 | 4,100 | 4,320 | 3,975 | 4,295 | +590 | +15.9% | 951,200 |
2017/10/26 | 3,660 | 3,740 | 3,635 | 3,705 | +75 | +2.1% | 91,700 |
2017/10/25 | 3,725 | 3,735 | 3,630 | 3,630 | -85 | -2.3% | 81,400 |
2017/10/24 | 3,715 | 3,730 | 3,670 | 3,715 | +5 | +0.1% | 53,100 |
2017/10/23 | 3,750 | 3,750 | 3,680 | 3,710 | +25 | +0.7% | 82,400 |
2017/10/20 | 3,610 | 3,695 | 3,605 | 3,685 | +90 | +2.5% | 93,500 |
2017/10/19 | 3,600 | 3,630 | 3,575 | 3,595 | -5 | -0.1% | 58,400 |
2017/10/18 | 3,575 | 3,605 | 3,550 | 3,600 | +20 | +0.6% | 40,900 |
2017/10/17 | 3,570 | 3,615 | 3,545 | 3,580 | +55 | +1.6% | 64,900 |
2017/10/16 | 3,560 | 3,565 | 3,515 | 3,525 | -60 | -1.7% | 84,900 |
2017/10/13 | 3,570 | 3,605 | 3,510 | 3,585 | +20 | +0.6% | 99,000 |
2017/10/12 | 3,580 | 3,610 | 3,515 | 3,565 | -10 | -0.3% | 106,800 |
2017/10/11 | 3,580 | 3,595 | 3,525 | 3,575 | -5 | -0.1% | 123,900 |
2017/10/10 | 3,660 | 3,680 | 3,545 | 3,580 | -100 | -2.7% | 227,500 |
2017/10/06 | 3,770 | 3,855 | 3,670 | 3,680 | -90 | -2.4% | 182,300 |
2017/10/05 | 3,830 | 3,950 | 3,760 | 3,770 | -60 | -1.6% | 230,700 |
2017/10/04 | 3,820 | 3,870 | 3,780 | 3,830 | +5 | +0.1% | 176,100 |
2017/10/03 | 3,715 | 3,870 | 3,715 | 3,825 | +155 | +4.2% | 269,800 |
2017/10/02 | 3,715 | 3,795 | 3,620 | 3,670 | +210 | +6.1% | 366,000 |
2017/09/29 | 3,415 | 3,520 | 3,405 | 3,460 | +40 | +1.2% | 158,800 |
2017/09/28 | 3,400 | 3,480 | 3,360 | 3,420 | +85 | +2.5% | 156,700 |
2017/09/27 | 3,295 | 3,385 | 3,295 | 3,335 | +15 | +0.5% | 122,300 |
2017/09/26 | 3,435 | 3,475 | 3,300 | 3,320 | -185 | -5.3% | 218,600 |
2017/09/25 | 3,340 | 3,510 | 3,335 | 3,505 | +180 | +5.4% | 367,500 |
1701~
1750
件表示中 / 6840件
類似銘柄と比較する
現在ご覧いただいている「JCRファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
JCRファーマ | 74,900円 | -3.7% | -36.7% | 2.67% | 24.66倍 | 1.61倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
ネクセラファーマ | 114,200円 | +197.7% | - | 0.00% | 46.67倍 | 1.49倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
杏林製薬 | 150,800円 | +3.2% | +4.5% | 3.45% | 17.32倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
栄研化 | 210,200円 | +0.4% | -8.4% | 2.52% | 27.78倍 | 1.58倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
サンバイオ | 96,800円 | - | - | 0.00% | - | 48.74倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム